SCHEMBL26835893

SCHEMBL26835893

Cc1ccc2c(c1CC(=O)OC(C)(C)C)CCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
HPGD P15428 4/20 0.42
HSD17B10 Q99714 4/20 0.42
KDM4E B2RXH2 3/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 2/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
NLRP3 Q96P20 3/20 0.36
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
METAP2 P50579 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22802398 0.87 KDM4E (0.39) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL20699038 0.84 HPGD (0.37) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL19475186 0.84 NLRP3 (0.47) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL21962078 0.82 MTNR1A (0.45) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL25067020 0.81 NLRP3 (0.45) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL22802351 0.78 DRD2 (0.38) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL22802391 0.78 RXRB (0.49) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL22802406 0.78 KDM4E (0.36) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL29691325 0.75 NLRP3 (0.42) ALDH1A1HPGDHSD17B10KDM4ETSHR
SCHEMBL23012413 0.75 NLRP3 (0.42) ALDH1A1HPGDHSD17B10KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11834433-B2 Compounds INFLAZOME LIMITED (IE) 2023-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11834433-B2 Compounds NLRP3, NOD1, PYCARD ALDH1A1 378/4885HPGD 275/4885HSD17B10 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.